Healthcare | February 15, 2024
Medanta launches monthly talk show around cardiac care - 'Heart 2 Heart'
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
The CDCCs are strategically positioned in regions identified as high-impact areas
The company is committed to a new category development in areas like adult Immunization with products like Shingrix to make a positive impact to the lives of the patients in India
These re-agent and diagnostic test kits come with 99.7% accuracy
The company recently received CEP certificate approval for Losartan Potassium by EDQM
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
Delivers keynote address at the 4th convocation of AIIMS Jodhpur
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
Subscribe To Our Newsletter & Stay Updated
